stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with acute cerebral infarction who meet the diagnostic criteria of Western medicine and have large vessel occlusion confirmed by cranial computed tomography angiography (CTA) magnetic resonance angiography (MRA) or full-brain digital subtraction angiography (DSA) which meets the indications for endovascular treatment [6]; (2) Receiving endovascular therapy including but not limited to arterial thrombolysis thrombosis mechanical thrombectomy balloon plasty stenting and stent implantation and recanalization (mTICI =2b); (3) Age 18~89 years old; (4) The pre-stroke Modified Rankin Score (mRS) score = 1 point; If the symptoms of neurological deficit caused by cerebral infarction appear the National Institutes of Health stroke scale (NIHSS) score United States 5~20 points after the onset of the disease. (5) Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with major organ failure or severe primary hematopoietic system diseases; (2) Patients with intracranial hemorrhage coagulation dysfunction or bleeding tendency before surgery; (3) Co-existing with severe infection; (4) Pregnant and lactating women and those with a history of allergy to drugs; (5) Patients with contraindications to acupuncture or those with severe primary diseases such as circulatory system respiratory system digestive system urinary system endocrine system and hematopoietic system after stroke and the condition cannot be controlled by conventional medication; Patients with tumors serious infections water-electrolyte and acid-base balance disorders; and other examination abnormalities that are judged by the investigator to be unsuitable for participating in this study. (6) Patients with severe aphasia sleep apnea deafness severe cognitive impairment and inability to communicate effectively; (7) Those who are currently participating in other clinical studies or have participated in other clinical studies for less than 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| National Institutes of Health stroke scaleNIHSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| modified Barthel index;Fugl-Meyer assessment scale;Rankin;Kubota drinking water test;Incidence of recurrence risk; | — |
Countries
China
Contacts
Dongguan TCM Hosptial Affiliated of Guangzhou University of Chinese Medicine